Introduction
Non-adherence is a significant barrier to using antiretroviral therapy (ART) in Africa (Harries et al. 2008) . Side effects to treatment; complex drug therapy regimens; patient-related factors such as alcohol abuse and lack of social support; are common barriers to ART adherence in both developed and developing countries (Mills et al. 2006a , Oliveira et al. 2010 . In sub-Saharan Africa, difficulties also include fear of stigmatisation; the need to travel long distances to receive treatment; poor documentation of treatment and lack of access to correct information (Unge et al. 2009; ). In addition, severe poverty and food insecurity aggravate cost-related barriers to adherence such as transport expenditure, registration and user fees at the private health facilities, and lost wages due to long waiting times (Hardon et al. 2007 , Yu et al. 2007 .
Early studies on adherence to HIV treatment in Africa have shown promising results with adherence levels equivalent to or exceeding those seen in Europe and the United States (Weiser et al. 2003 , Mills et al. 2006b ). Yet, sub-optimal levels of adherence in Africa have also been reported (Rosen et al. 2007 , Wakabi, 2008 . Several studies have shown that adherence rates decrease significantly over time (Godin et al. 2005 , Lima et al. 2009 ).
Low adherence levels in Africa could threaten current and future ART programme. It is therefore crucial to address the factors leading to non-adherence and target the available resources accordingly (Jaffar et al. 2008) .
Guinea-Bissau is a West African country situated between Senegal, Guinea Conakry and the Atlantic Ocean. In 2010 the population was estimated at 1.6 million people; the nation is currently ranked among the 10 poorest countries in the world (UNDP 2011; US Department of State 2012). The HIV epidemic in Guinea-Bissau has changed drastically over the past 20 years. The country has had the highest prevalence of HIV-2 in West Africa for many years, while HIV-1 was absent only two decades ago (Poulsen et al. 1992 , Poulsen et al. 1993 , Wilkins et al. 1993 , Larsen et al. 1998 ). In rural Guinea-Bissau, the HIV-1 prevalence Barriers and facilitators to antiretroviral therapy adherence among patients with HIV in Bissau, Guinea-Bissau: A qualitative study rose from 0.5% in 1990, to 3.6% in 2007; HIV-2 decreased from 8.3% to 4.7% in the same period (Tienen et al. 2010) . The same trend has been observed repeatedly in studies conducted in urban Guinea-Bissau (Da Silva et al. 2008 , Mansson et al. 2009 ). In 2009 UNAIDS estimated that 2.5% of the adult population was infected with HIV (UNAIDS/ WHO 2009). Current data show that the estimated prevalence has reached a new peak of 5.8% (INASA 2011) . This prevalence is worryingly high compared to that of neighbouring countries such as Senegal and GuineaConakry which both have HIV prevalence's estimated at 2% or lower (UNAIDS, 2010) . Guinea-Bissau has a prevalence that may reach the levels of the most affected countries in sub-Saharan Africa. Research aiming to understand and address the HIV epidemic in Guinea-Bissau is therefore urgently warranted.
The National HIV Programme was first implemented by the Guinean Ministry of Health in 2005. ART has since been available in the country thanks to the sponsorship of the drugs by Global Fund and the Brazilian Government. At the end of 2009 the country had 26 ART centres with more than 7,000 patients on follow-up and 2,764 people receiving treatment (UNGASS 2010) . All treatment is free of charge in the country, but drug supply has been inconsistent (Oliveira et al. 2010) .
Despite numerous studies investigating and describing causes of non-adherence, few qualitative studies on ART adherence have been conducted in resource poor countries (Mills et al. 2006a) . To the best of our knowledge, no reports of previous studies are available on ART adherence in Guinea-Bissau. The scope of this study was to examine and conceptualise barriers and facilitators to adherence among people undergoing ART.
Methods
This study was conducted from August to December 2009. For data collection and analysis, we chose a grounded theory design, aimed at generating theory rather than mere description (Glaser and Strauss 1967) . Grounded theory encompasses a specific methodology on how to get from systematic data collection to producing a multivariate conceptual theory. It provides a series of systematic, exact methods that start with collecting data and guides the researcher through the analytical process. The theory considers cultural diversity, making it an appropriate method for this study. The aim of grounded theory is to generate concepts, a model or a substantive theory which is complete, coherent and sheds light on the area under study rather than testing hypotheses based on existing theory. The analysis generates codes, categories and concepts, in which the substantive code is the most concrete level and the core category the most abstract Strauss 1967, Glaser and Holton 2007) .
Study participants and setting
We conducted 20 semi-structured interviews with HIV patients on ART. Patients were recruited by purposive sampling at the Simão Mendes HIV Treatment Center in Bissau, Guinea-Bissau. In December 2009 this study site had 1 313 HIV patients in follow-up, of whom 62% (812 patients) were using ART. The health care providers (HCPs), at the centre, were asked to identify and recruit relevant adherent and non-adherent men and women, aged between 15 and 65 years, undergoing ART for more than one month. The degree of adherence was assessed during drug administration based on pill counts, self report and clinic attendance. Patients were given an exact number of pills for either one or two months with an extra of three pills in case clinical visits were delayed. Pill count adherence was calculated as the absolute value of the number of pills the patient took divided by the number of pills that should have been taken since the last prescription refill. Seven pills or below the correct amount to be taken was considered adherent. Clinical visits and scheduled visits were also recorded in patient journals. Patients who failed to visit the clinic before prescriptions ran out were categorised as non adherent. Patients agreeing to participate gave informed consent before being introduced to the researcher. The sample (n = 20) comprised 45% men and 55% women. Of the participants, 25% were single, 50% were married and 25% were divorced, separated or widowed. The median age was 44 years for men and 33 years for women. Period of time on ART ranged from 1 to 48 months with a median of 18 months for men and 22 months for women.
Data collection
Data were collected using open, semi-structured interviews with each patient. The intention was to uncover the interviewees' perspectives in-depth, with interviews lasting 1-1½ hours.
The questions were open-ended, however, an interview guide was used to cover fixed themes such as: patient's perception and knowledge of HIV/AIDS; information received about ART; perceived barriers and facilitators to ART; and experiences before and after starting ART. In addition, notes and memos were written after each interview. Often, the patient's own words were used to confirm that the indentified words or phrases were really grounded in the data, rather than being generated from an implicit hypothesis or from the researcher's preconceptions.
Data analysis
Digital audio recordings of the interviews were transcribed verbatim by a Kriol-English interpreter present during each interview. The interviews were entered into the NVIVO 2.1 computer program (NVivo2 2002), which helped structure and manage the data. The analytic process included open, selective, and theoretical coding. In the open coding process, the transcripts were inductively analysed line by line, and several codes were developed to assess the data. Subsequently, the open codes were clustered into categories. After an analysis of the first eight interviews, the core category 'HIV-related knowledge' emerged as a main concern, which was ethnographically faithful and enduring beyond the single participants. Once the core category was generated, the sampling became selective in line with this category. Sub-categories and their properties were developed using further data collection (12 interviews) and a constant comparison of the data as a whole. In the theoretical phase of the analysis, the relationships between the core category and its sub-categories were determined and described. The process continued until no new African Journal of AIDS Research 2013: 1-8 3 properties emerged and theoretical saturation was reached. In accordance with the grounded theory method (Glaser and Strauss 1967) , memos were written during the entire analytical process to record ideas about emerging categories and assumptions about their relationships. The main analysis was done by the primary investigator (PI) with continuous review from all co-authors.
Data credibility
Interviews were conducted in Guinea-Bissau's local language, Kriol (a Portuguese-based Creole, the lingua franca), by the PI, who is not a native Kriol speaker, with assistance from a native interpreter. The interpreter was present during all interviews, ensuring that questions were worded correctly and that any questions or answers not understood by the interviewee or interviewer could be clarified. To strengthen validation, the PI and the interpreter discussed and compared notes after each interview (Kvale and Brinkmann 2009 ). All interview recordings were transcribed into Kriol and subsequently translated into English by a professional interpreter. The PI and interpreter compared all transcripts with the MP3 audio recordings to ensure key points and vital data were not lost in translation. The process of data collection and analysis is illustrated in (Figure 1 ).
Ethical issues and approval
Potential participants were recruited by an adherence nurse during either prescription refill or consultations. After written consent was obtained, patient names and data were given to the researcher. Participants were informed that all data would remain confidential, and that declining to participate in the study would in no way affect their access to treatment. The study was approved by the Guinean Ethics Committee in November 2008.
Results
After an analysis of eight interviews the core category HIV-related knowledge emerged. Alongside this core category, five additional subcategories were uncovered. Data saturation was obtained after 16 interviews; the final 4 interviews did not present any new information, rather, they strengthened the core category of the theory. In the following sections we present the core category followed by the sub-categories.
HIV-related knowledge
The findings indicate that HIV-related knowledge, a form of health literacy was the most important factor influencing patient adherence. The term refers to having appropriate information and knowledge about HIV and understanding that ART is a lifelong treatment demanding good adherence. HIV-related knowledge can either be a barrier if knowledge is limited or a facilitator, depending on a patients' understanding of the favourable effects of HIV treatment and the harmful consequences of non-adherence. Even very basic HIV-related knowledge is sufficient to help patients adhere to treatment. One patient revealed: ' (woman, age 27 ). None of our study participants could name the pills they took. They had difficulty differentiating between pills because of illiteracy and because almost all the generic ART drug bottles looked similar. Some participants were unsure whether discontinuing treatment was harmful. A patient who had been in treatment for two years asked about stopping:
'This treatment that brings me here, can I never stop taking it?' (woman, age 56) Despite being on treatment for a long period of time, some patients had not understood that HIV demanded lifelong treatment.
Facilitators to treatment adherence

Experienced treatment benefits
Experiencing improved health after starting treatment was reported as a strong motivator for patients to adhere to ART. Those experiencing health improvements reported that ART provided them with the strength to work, support their family and increased their overall quality of life:
' 
Barriers to treatment adherence
Treatment related costs and competing livelihood needs
The impact of poverty (e.g. food insecurity, and limited funds for transportation and non-ART medications), emerged as an important barrier to adherence. Patients reported difficulties taking ART on empty stomachs; some would postpone medication until they succeeded in getting food, convinced that ART could not be taken otherwise. Others explained that they would skip doses if they were unable to find something to eat because they felt that antiretrovirals 'tired them' and lead to general discomfort and increased hunger: [medication] ' (man, age 29). Lack of money for transport also contributed to non-adherence. Patients described how they had to divert already limited funds to more pressing necessities, such as food and other non-ART medication, and how they often . Nearly all participants were familiar with traditional medicine and many had earlier experiences with its use. Only one patient responded she had taken traditional medicine specifically to treat HIV. Nevertheless, patients disagreed about whether traditional medicine could cure HIV.
'If I haven't had breakfast I don't take it [medication] in the morning. I only take it at lunch time when I am full. It's like that. If I don't eat I can't take it
Discussion
Our results show that health literacy (Sorensen et al. 2012) in the form of HIV-related knowledge was a central concept regarding patient adherence. The results also underline the importance of gaining an increased understanding of the relationship between HIV-related knowledge and ART adherence.
In line with other studies, our findings emphasise the importance of ensuring appropriate HIV-related knowledge (Kumarasamy et al. 2005; Anuradha et al. 2013) . Poor HIV-related knowledge is a structural barrier which, to a large extent, is a consequence of living in a resourceconstrained environment (Kagee and Delport 2010) . Guinea-Bissau is one of the poorest countries in the world. The adult literacy rate in the country is estimated to be 52% (World Bank 2012) . Studies have demonstrated that low levels of literacy and poor information about ART negatively affect adherence (Mills et al. 2006a, Trzynka and Erlen 2004) .
Knowledge of medication instructions is a precondition for adherence. Furthermore, HIV-related knowledge may also promote the development of adherence related skills and increase motivation (Weiss et al. 2003) . Poor HIV-related knowledge is a potentially modifiable barrier to adherence. More focus on intensifying counselling services by HCPs could equip patients with the necessary knowledge to cope with the physical, financial and social barriers to adherence. Our findings support those from other studies that advocate for the design of ART adherence interventions tailored to lower-literacy populations (Kalichman et al. 2008) . Simple, low cost counselling tools such as pictorials and the use of culturally modified metaphors may help to increase patient 6 HIV-related knowledge and thereby overall adherence.
Social relationships are principle mediators to sustaining adherence in sub-Saharan Africa (Edwards 2006 , Ware et al. 2009 ). Our study found that some patients were able to access support from their family and friends, thereby obtaining better help, despite hiding their HIV-status. This is contrary to results from other studies that suggest disclosure is imperative for achieving social support (Coetzee et al. 2011) . Despite this finding our study suggests increasing disclosure may help patients to access more social capital. Nevertheless, this may first be possible if stigma in the general population decreases.
Antiretrovirals are free of charge in many places in Africa, including Guinea-Bissau, but treatment-related expenses still hinder patients' access to treatment (Tuller et al. 2010, Badahdah and Pedersen 2011) . Our findings are in concordance with those from other studies which have found that lack of food due to poverty is a common obstacle to patients taking their treatment (Nachega et al. 2006 , Hardon et al. 2007 , Sanjobo et al. 2008 , Kagee and Delport 2010 . In addition, our study showed patients would skip or delay medication if they had not eaten. Poor HIV-related knowledge coupled with financial constraints might complicate a patient's ability to access a steady ART supply because they risk prioritising erroneously, thereby opting against their lifesaving medication. Informants in our study described poor clinical infrastructure, with insufficient facilities for conducting confidential consultations, prevented patients from communicating openly with HCPs. Insufficient counselling could facilitate misunderstandings about taking ART, leading to lower adherence. Studies from Botswana and Senegal have suggested that HIV patients tended to reduce clinical visits because of the risk of being seen by others and potentially having their HIV status exposed (Laniece et al. 2003 , Weiser et al. 2003 . Creating infrastructure that is more agreeable to patient confidentiality is imperative.
Perceived stigma, due to a general lack of knowledge in the public sphere about HIV, appeared to be considerable as it resulted in patients fearing disclosure. A national survey from Guinea-Bissau showed that approximately 30% would reportedly leave their partner and 59% would abandon a relative if he or she was infected with HIV (Bandim Health Project et al. 2009 ). In many African countries HIV-related stigma and discrimination is highly prevalent leading to lower rates of disclosure (Greeff et al. 2008) . However, if discrimination is low, it appears disclosure will have more advantages, such as obtaining social support and increased empowerment (Sandelowski et al. 2004) . Interventions targeting communities have been shown to increase acceptability of HIV-infected individuals and further reduce discriminatory attitudes (Brown et al. 2003 , Babalola et al. 2009 ). Greater efforts to improve social awareness in the general public could lessen societal stigma, thereby reducing difficulties associated with disclosure and increasing adherence among HIV-infected people.
Our study indicates that traditional treatment is a worrying antagonist to biomedical therapy. Traditional treatment is appealing because it is easily accessible, cheap, and often guarantees a cure in contrast to biomedical medicine. A study from South Africa found that traditional healers occasionally advise patients to stop ART (Dahab et al. 2008 ). In addition, Coetzee et al. (2011) reported some charismatic churches encouraging the discontinuation of treatment (Coetzee et al. 2011) . Our findings suggest that family and tribal elders also play a central role in decision making regarding treatment for HIV. If elders favour traditional practices their counselling might have a negative effect on patients adhering to biomedical treatment. Traditional, religious and social discouragers may be underexplored causes of non-adherence which must be investigated and addressed when commencing ART in countries such as Guinea-Bissau. HCPs must achieve a deeper understanding and clarification of ways to counsel patients on the use of traditional medicine and on how to tackle influence exerted by family, religious and tribal leaders.
The results of this study should be interpreted in the light of several important limitations. Firstly, these findings are context-specific and might not be generalisable to other settings, although the concepts may be able to shed light on problems in other African countries. Secondly, patients were recruited using purposive sampling from one outpatient clinic, primarily treating patients from an urban community in Bissau, Guinea-Bissau. The sample might not be representative of all HIV-patients in our study population. The presence and conducting of interviews by a foreign interviewer might have had an effect on participant openness.
Conclusion
This is the first study conducted regarding HIV and adherence in Guinea-Bissau. It shows that barriers to adherence in Guinea-Bissau are similar to those in other African countries. Nevertheless, this study also demonstrates that HIV-related knowledge is a determining factor for ART adherence which should not be forgotten in the race to achieve 'universal access'. Our findings indicate that greater efforts are needed to educate HIV patients sufficiently about HIV, ART and lifelong treatment. More targeted research on ART adherence and HIV-related knowledge in GuineaBissau is needed. We are therefore currently conducting a larger quantitative study which will shed further light on the barriers and facilitators to ART adherence.
